Elliot E, Polli JW, Patel P, Garside L, et al. Efficacy, safety, and pharmacokinetics by BMI category in Phase 3/3b cabotegravir + rilpivirine long-acting trials. J Infect Dis 2023 Dec 22:jiad580. doi: 10.1093.
PMID: 38134313